Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
EPA CPDat observed this chemical in 16177 composition records across product categories including Cleaning and safety, Construction and building materials, Raw materials.
Concern score
The concern value is driven by the published classifications and regulatory status below — not by a single signal.
Concern score 45/100 (moderate) · high confidence.
Prevalence of PROPYLENE GLYCOL in our catalog (epa_cpdat).
Products
16,177
Brands
6
Typical roles
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
Fragrance avoidance
Not a strong fit for fragrance avoidance because it carries Fragrance.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
EPA
EPA CPDat observed this chemical in 16177 composition records across product categories including Cleaning and safety, Construction and building materials, Raw materials. EPA CPDat classifies this chemical for functional uses including Solvent, Stabilizing agent, Humectant.
US
FDA
Route: AURICULAR (OTIC); Dosage form: SOLUTION; Potency: 56.55 %w/v
US
FDA
The ingredient itself is a fragrance-linked signal, so it is better treated as an avoid case when fragrance exposure is the main concern.
The published evidence profile currently shaping this ingredient record.
Route: AURICULAR (OTIC); Dosage form: SOLUTION/ DROPS; Potency: ADJ PH
US
FDA
Route: AURICULAR (OTIC); Dosage form: SUSPENSION; Potency: 10 %w/v
US
FDA
Route: BUCCAL; Dosage form: FILM, SOLUBLE; Maximum daily exposure: 5 mg
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION; Maximum daily exposure: 7459 mg
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 4000 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION; Maximum daily exposure: 16624 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: 63.4 %w/v
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 4000 mg
US
FDA
Route: INTRAVENOUS; Dosage form: SOLUTION; Potency: 5 %w/v
US
FDA
Route: INTRAVENOUS; Dosage form: SOLUTION, CONCENTRATE; Potency: 50.33 %w/v
US
FDA
Route: NASAL; Dosage form: SPRAY; Maximum daily exposure: 5 mg
US
FDA
Route: NASAL; Dosage form: SPRAY, METERED; Maximum daily exposure: 240 mg
US
FDA
Route: OPHTHALMIC; Dosage form: EMULSION; Potency: 1.5 %w/v
US
FDA
Route: OPHTHALMIC; Dosage form: GEL; Potency: 0.44 %w/w
US
FDA
Route: OPHTHALMIC; Dosage form: SOLUTION; Potency: 1 %w/v
US
FDA
Route: OPHTHALMIC; Dosage form: SOLUTION/ DROPS; Potency: 0.75 %w/v
US
FDA
Route: OPHTHALMIC; Dosage form: SUSPENSION; Potency: 0.6 %w/v
US
FDA
Route: OPHTHALMIC; Dosage form: SUSPENSION/ DROPS; Potency: 0.75 %w/v
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 1072 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, COATED; Potency: 25 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, COATED, EXTENDED RELEASE; Potency: NA
US
FDA
Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Potency: 1.7 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 8 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, LIQUID FILLED; Maximum daily exposure: 42 mg
US
FDA
Route: ORAL; Dosage form: CONCENTRATE; Maximum daily exposure: 7000 mg
US
FDA
Route: ORAL; Dosage form: ELIXIR; Maximum daily exposure: 9306 mg
US
FDA
Route: ORAL; Dosage form: LIQUID; Maximum daily exposure: 29008 mg
US
FDA
Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 22602 mg
US
FDA
Route: ORAL; Dosage form: SOLUTION, CONCENTRATE; Maximum daily exposure: 2590 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 27120 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION, EXTENDED RELEASE; Maximum daily exposure: 1000 mg
US
FDA
Route: ORAL; Dosage form: SYRUP; Maximum daily exposure: 5700 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 64 mg
US
FDA
Route: ORAL; Dosage form: TABLET, COATED; Maximum daily exposure: 16 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 36 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Potency: 9 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 96 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED, EXTENDED RELEASE; Maximum daily exposure: 19 mg
US
FDA
Route: RECTAL; Dosage form: AEROSOL, FOAM; Maximum daily exposure: 1214 mg
US
FDA
Route: RECTAL; Dosage form: AEROSOL, METERED; Potency: NA
US
FDA
Route: RECTAL; Dosage form: GEL; Maximum daily exposure: 3315 mg
US
FDA
Route: RECTAL; Dosage form: OINTMENT; Maximum daily exposure: 27 mg
US
FDA
Route: RECTAL; Dosage form: SUSPENSION; Maximum daily exposure: 90400 mg
US
FDA
Route: RESPIRATORY (INHALATION); Dosage form: LIQUID; Potency: 10 %w/w
US
FDA
Route: RESPIRATORY (INHALATION); Dosage form: SOLUTION; Potency: 25 %w/w
US
FDA
Route: SUBCUTANEOUS; Dosage form: INJECTION; Potency: 1.4 %w/v
US
FDA
Route: SUBCUTANEOUS; Dosage form: INJECTION, SOLUTION; Potency: 1.4 %w/v
US
FDA
Route: SUBLINGUAL; Dosage form: SPRAY; Maximum daily exposure: 36 mg
US
FDA
Route: TOPICAL; Dosage form: AEROSOL; Potency: 19.2 %w/w
US
FDA
Route: TOPICAL; Dosage form: AEROSOL, FOAM; Maximum daily exposure: 1800 mg
US
FDA
Route: TOPICAL; Dosage form: CLOTH; Potency: 0.03 mg/mg
US
FDA
Route: TOPICAL; Dosage form: CREAM; Maximum daily exposure: 6113 mg
US
FDA
Route: TOPICAL; Dosage form: CREAM, AUGMENTED; Potency: 8 %w/w
US
FDA
Route: TOPICAL; Dosage form: EMULSION; Potency: 8 %w/w
US
FDA
Route: TOPICAL; Dosage form: GEL; Maximum daily exposure: 4522 mg
US
FDA
Route: TOPICAL; Dosage form: GEL, METERED; Maximum daily exposure: 1225 mg
US
FDA
Route: TOPICAL; Dosage form: LOTION; Maximum daily exposure: 3392 mg
US
FDA
Route: TOPICAL; Dosage form: LOTION, AUGMENTED; Maximum daily exposure: 2070 mg
US
FDA
Route: TOPICAL; Dosage form: OINTMENT; Maximum daily exposure: 5148 mg
US
FDA
Route: TOPICAL; Dosage form: OINTMENT, AUGMENTED; Maximum daily exposure: 714 mg
US
FDA
Route: TOPICAL; Dosage form: SHAMPOO, SUSPENSION; Potency: 2 %w/w
US
FDA
Route: TOPICAL; Dosage form: SOLUTION; Maximum daily exposure: 4886 mg
US
FDA
Route: TOPICAL; Dosage form: SUSPENSION; Potency: 5.28 %w/v
US
FDA
Route: TOPICAL; Dosage form: SUSPENSION/ DROPS; Potency: 0.75 %w/v
US
FDA
Route: TOPICAL; Dosage form: SYSTEM; Maximum daily exposure: 4200 mg
US
FDA
Route: TRANSDERMAL; Dosage form: FILM, EXTENDED RELEASE; Potency: 58.13 mg
US
FDA
Route: TRANSDERMAL; Dosage form: GEL; Maximum daily exposure: 500 mg
US
FDA
Route: VAGINAL; Dosage form: AEROSOL, FOAM; Potency: 6.4 %w/w
US
FDA
Route: VAGINAL; Dosage form: CREAM; Maximum daily exposure: 1225 mg
US
FDA
Route: VAGINAL; Dosage form: GEL; Maximum daily exposure: 750 mg
US
FDA
Route: VAGINAL; Dosage form: SUPPOSITORY; Potency: 252 mg
US
FDA
FDA NDC lists this ingredient in 97 active drug products and 114 total products.
US
FDA
openFDA substance registry classifies this ingredient as chemical.